RLFTF

RELIEF THERAPEUTICS HLDG by RELIEF THERAPEUTICS HLDG AG (RLFTF)

About RELIEF THERAPEUTICS HLDG by RELIEF THERAPEUTICS HLDG AG (RLFTF)

RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It operates through the following geographical segments: Switzerland, Europe, North America, and Rest of the World. The company was founded in 2013 and is headquartered in Geneva, Switzerland.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$7.66
52 Week Low
$2.25
Market cap
45.5M
Dividend yield
0.00%
Volume
129
Avg. volume
2,797
P/E ratio
-2.31

RELIEF THERAPEUTICS HLDG by RELIEF THERAPEUTICS HLDG AG News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$7.66
52 Week Low
$2.25
Market cap
45.5M
Dividend yield
0.00%
Volume
129
Avg. volume
2,797
P/E ratio
-2.31